Documentation scienceplus.abes.fr version Bêta

À propos de : Psychiatric Treatment of Eczema: A Controlled Trial        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Psychiatric Treatment of Eczema: A Controlled Trial
has manifestation of work
related by
Abstract
  • Seventy-two patients with eczema were randomly allotted to one of two treatment groups: A, those receiving dermatological treatment only, and B, those receiving the same dermatological treatment plus psychiatric treatment, limited where possible to four months. Cases were followed up at six-monthly dermatological assessments, 57 (79%) for 18 months. The findings suggest that in the presence of overt emotional disturbance, of new psychological or psychophysiological symptoms preceding the rash by up to a year, and of high motivation for it, brief psychiatric treatment improves the outcome in eczema (the proportion clear at 18 months was about doubled), whereas in their absence such treatment may worsen it, especially in the short term.
article type
is part of this journal
PubMed ID
  • 5090759



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata